Nina Niu Sanford: Liver transplant and chemotherapy to colorectal cancer with unresectable liver metastasis
Nina Niu Sanford shared on X/Twitter:
“TRANSMET: addition of liver transplant to chemotherapy in colorectal cancer with unresectable liver metastasis: big OS benefit (5 year 57% v 13%).
Curve plateauing at 5 years suggests ~1/2 patients can be cured!
Challenge is liver availability – on trial, prioritization < 2 months after completing chemotherapy.
Great discussion by Dr. Lee with shoutout to Gonzalo Sapisochin liver transplant program in Toronto!”
Source: Nina Niu Sanford/X
Dr. Nina Niu Sanford is an Assistant Professor and Chief of Gastrointestinal Radiation Oncology at Harvard/Brigham and Women’s Hospital/Massachusetts General Hospital.
She specializes in treating gastrointestinal cancers and actively participates in clinical trials combining high-dose radiation therapy with immunotherapy. Additionally, she researches healthcare access disparities and conducts pan-cancer outcomes research using large databases.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023